Apelin and heart remodeling in patients with abdominal obesity
https://doi.org/10.24884/1607-4181-2015-22-2-17-19
Abstract
About the Authors
O. V. ListopadRussian Federation
E. A. Bazhenova
Russian Federation
V. A. Ionin
Russian Federation
O. D. Belyaeva
Russian Federation
E. I. Baranova
Russian Federation
References
1. Беляева О. Д., Баженова Е. А., Березина А. В. и др. Уровень адипонектина, показатели липидного и углеводного обменов у пациентов с абдоминальным ожирением // Артериальная гипертензия. - 2009. - Т. 15. - № 3. - С. 309-313.
2. Руденко Т. Е., Кутырина И. М. Ожирение как фактор сосудистого ремоделирования // Клин. нефрол. - 2010. - № 3. - С. 62 - 67.
3. Ashley E. A., Powers J., Chen M. et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo // Cardiovasc. Res. - 2005. - Vol. 65 (1). - P. 73 - 82.
4. Ashrafian H., Athanasiou T., le Roux C. Heart remodeling and obesity: the complexities and variation of cardiac geometry// Heart. - 2011. - Vol. 97. - P. 171 - 172.
5. Baena-Dэez J. M., Byram A. O., Grau M. et al. Obesity and the risk of heart failure // Clin. Cardiol. - 2010. - Vol. 33 (12). - P. 760 - 764.
6. Dai T., Ramirez-Correa G., Gao W. D. Apelin increases contractility in failing cardiac muscle // Eur. J. Pharmacol. - 2006. - Vol. 553 (1-3). - P. 222 - 228.
7. Dale Abel E., Litwin S., Sweeney G. Cardiac Remodeling in Obesity // Physiological Reviews. - 2008. - Vol. 88. - № 2. - P. 389 - 419.
8. De Simone G. Morbid Obesity and Left Ventricular Geometry // Hypertension. - 2007. - Vol. 49. - P. 7 - 9.
9. Hoefle G., Saely C. H., Aczel S. et al. Impact of total and central obesity on vascular mortality in patients undergoing coronary angiography // Int. J. Obes. - 2005. - Vol. 29. - P. 785 - 791.
10. Li Z., Bai Y., Hu J. Reduced apelin levels in stable angina // Intern. Med. - 2008. - Vol. 47(22). - P. 1951 - 1955.
11. Lieb W., Sullivan L. M., Aragam J. et al. Relation of Serum Leptin With Cardiac Mass and Left Atrial Dimension in Individuals >70 Years of Age // American Journal of Cardiology. - 2009. - Vol. 104. - Is. 4. - P. 602 - 605.
12. Mattu H. S., Randeva H. S. Role of adipokines in cardiovascular disease // J. of Endocrinology. - 2013. - Vol. 216. - P. 17 - 36.
13. McManus D., Lyass A., Ingelsson E. et al. Relations of Circulating Resistin and Adiponectin and Cardiac structure and Function: the Framingham Offspring study // Obesity. - 2012. - Vol. 20 (9). - P. 1882-1886.
14. Pisarenko O. I., Serebryakova L. I., Pelogeykina Y. A. et al. In vivo reduction of reperfusion injury to the heart with apelin-12 peptide in rats // Bull. Exp. Biol. Med. - 2011. - Vol. 152 (1). - P. 79 - 82.
15. Prado C., Vasconcelos G. et al. Evaluation of Visceral and Subcutaneous Fat by Ultrasound and Its Relationship with Clinical and Metabolic Parameters of Insulin Resistance and Subclinical Atherosclerosis // Open Journal of Endocrine and Metabolic Diseases. - 2012. - Vol. 2. - P. 63 - 69.
16. Yusuf S., Hawken S., Ounpuu S. et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case -control study //Lancet. - 2005. - Vol. 366. - P. 1640-1649.
Review
For citations:
Listopad O.V., Bazhenova E.A., Ionin V.A., Belyaeva O.D., Baranova E.I. Apelin and heart remodeling in patients with abdominal obesity. The Scientific Notes of the Pavlov University. 2015;22(2):17-19. (In Russ.) https://doi.org/10.24884/1607-4181-2015-22-2-17-19